Analyze and apply critical thinking skills in the psychopathology of mental health patients and provide treatment and health promotion while applying evidence-based research.Scenario:
C.Z. is a 20-year-old Caucasian male who is in his second year of college. He is seeking treatment due to persistent fears that campus security and the local police are tracking and surveilling him. He cites occasional lags in his internet speed as evidence that surveillance devices are interfering with his electronics. His intense anxiety about this has begun getting in the way of his ability to complete schoolwork, and his friends are concerned – he says they have told him, “you’re not making sense.”
C.Z. occasionally laughs abruptly and inappropriately and sometimes stops speaking mid-sentence, looking off in the distance as though he sees or hears something. He expresses concern about electronics in the room (phone, computer) potentially being monitored and asks repeatedly about patient confidentiality, stating that he wants to be sure the police won’t be informed about his treatment. His beliefs are fixed, and if they are challenged, his tone becomes hostile.
Questions:
Remember to answer these questions from your textbooks and NP guidelines. At all times, explain your answers.
Discuss the etiology, course, and the structural/functional abnormalities of schizophrenia.
Discuss the evidence-based pharmacological and nonpharmacological treatment for this patient using the US Clinical Guidelines.
Submission Instructions:
Your initial post should be at least 500 words, formatted and cited in current APA style with support from at least 2 academic sources. Your initial post is worth 8 points.
Guide On Rating System
Vote
Schizophrenia is a chronic mental disorder characterized by disruptions in thinking, perception, emotions, and behavior. The etiology of schizophrenia is multifactorial, involving a combination of genetic, neurobiological, and environmental factors. While the exact cause is unknown, researchers believe that a combination of genetic vulnerability and environmental stressors play a significant role in the development of the disorder.
Genetic factors contribute to the risk of developing schizophrenia. Family and twin studies have shown that individuals with a first-degree relative, such as a parent or sibling, with schizophrenia have a higher risk of developing the disorder themselves. However, it is important to note that genetics alone are not sufficient to cause the development of schizophrenia. Environmental factors, such as prenatal exposure to viral infections, maternal stress during pregnancy, and complications during birth, can also contribute to the risk.
Neurobiological abnormalities in schizophrenia have been extensively studied. Structural abnormalities in the brain, particularly in the prefrontal cortex, hippocampus, and amygdala, have been found in individuals with schizophrenia. These abnormalities can affect cognitive and emotional functioning and contribute to the symptoms of the disorder. Functional abnormalities in neurotransmitter systems, particularly dopamine and glutamate, have also been observed in individuals with schizophrenia. Dysfunction in these systems can lead to disruptions in information processing and contribute to the positive, negative, and cognitive symptoms of the disorder.
The course of schizophrenia varies among individuals, but it is generally characterized by episodic periods of symptom exacerbation and remission. The onset of symptoms typically occurs in late adolescence or early adulthood, which aligns with the age of onset in the case of C.Z. Without appropriate treatment, symptoms can persist and significantly impair functioning and quality of life.
The treatment of schizophrenia involves a multimodal approach that combines pharmacological and nonpharmacological interventions. The US Clinical Guidelines for the treatment of schizophrenia recommend the use of antipsychotic medications as the first-line treatment. There are two classes of antipsychotic medications: first-generation (typical) antipsychotics and second-generation (atypical) antipsychotics. Both classes have been shown to be effective in reducing positive symptoms (e.g., hallucinations, delusions) but have varying side effect profiles.
Nonpharmacological interventions are also an essential component of the treatment for schizophrenia. Psychosocial interventions, such as cognitive-behavioral therapy (CBT), family therapy, and supported employment, have been shown to be effective in reducing symptoms, improving functioning, and promoting recovery. CBT can help individuals challenge and modify their distorted thoughts and beliefs, such as C.Z.'s fixed and delusional beliefs about surveillance. Family therapy can provide education and support to both the individual and their family members, helping them understand the illness and develop coping strategies. Supported employment programs can help individuals with schizophrenia find and maintain employment, promoting social integration and recovery.
In conclusion, the case of C.Z. presents a classic presentation of schizophrenia, characterized by delusional beliefs, hallucinations, and fragmented speech. The etiology of schizophrenia involves a combination of genetic, neurobiological, and environmental factors. Treatment for schizophrenia should include both pharmacological and nonpharmacological interventions, with antipsychotic medications as the first-line treatment and psychosocial interventions to support recovery. It is crucial to apply evidence-based research and guidelines to ensure the best possible treatment and health promotion for individuals with schizophrenia.
Got a question with my answer?
Cheapmath.com is completely free!
Asking question is free.
Getting answers is free.
+99